Madrigal Pharmaceuticals

US · MDGL #1355 by market cap Listed 2016

484.63 -3.09 -0.63%

Live - 5344 symbols - heartbeat 468s ago · 2026-10-08 10:00

Pre-market 498.89 +2.29%

After-hours 487.72 0.00%

Market cap: 11.20B
P/E (TTM): -34.64
P/B: 21.38
EPS: -12.85
Div yield: 0.00%
52W pos: 41%

Reader sentiment Are you bullish or bearish on MDGL?

Anonymous reader poll. Unscientific, not investment advice.

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Founded: 2000
CEO: Mr. William John Sibold
Employees: 915
Headquarters: West Conshohocken, Pennsylvania, United States of America
Fiscal year end: 12-31
Website: madrigalpharma.com

Company profile

Exchange: US
Symbol: MDGL
Market-cap rank: #1355
Listing date: 2016-07-25
Market cap: 11.20B
Float cap: 6.65B
Shares out: 23.10M
Float shares: 13.72M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 10:00:09 · For reference only, not investment advice and not tailored to your situation.